REALATED ARTICLES

Click on a word or phrase in our Tag Cloud and see all related articles listed below.

Current tag:

No Mercy with Violators of Corporate Compliance

Dr Rüdiger Scheitza, Member of the Board Bayer CropScience, and Labour Director

(C) Wolf G Kroner 2010 September 2010. Global companies operate in different jurisdictions with legal frameworks rooted in regional customs and traditions. Doing business in a correct manner or legally acceptable ways quickly becomes complex the wider the cultures are apart.

Corporate governance and compliance policies are means to ensure conformity with sometimes widely differing laws as well as providing for smooth flow of international transactions. While companies are eager to publish their guidelines, many of them remain rather secretive in public, how they implement these No wonder, that some regard such policies as waste paper or a front.B2Bioworld asked Dr Rüdiger Scheitza, Member of the Board Bayer CropScience, and Labour Director.

Roche Ethiopia: Build-up of an emerging market

The Global Dimension of EU Health and Food Policies

Paola Testori-Coggi, Director-General for Health and Consumers, European Commission

If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

Stem Cell Insights Collection 2010

Issues and Evaluation from Pharma Leaders

How does the pharma industry view application of stem cell technologies? Where are R&D efforts needed, and where does academic research not fulfill expectations? What is the role of suppliers in the field?

Read fresh answers from the leaders, provided exclusively to readers of B2Bioworld. Published only here, and all in one.

(C) Boehringer Ingelheim (C) Wolf G Kroner 2009 (C) Hoffmann-La Roche 2009

We are obliged to more and more move away from animal models
- Prof. Andreas Barner, Boehringer Ingelheim

Preparing for Another Level of Innovation
- Dr Mark Fishman, Novartis

Clear away complete confusion of terms
- Dr Bernhard Kirschbaum, Merck Serono

Stem Cells: a discovery tool and a potential therapeutic modality
- Dr Jonathan Knowles, Hoffmann-La Roche

It really started last year…
- Dr Ruth McKernan, Pfizer Regenerative Medicine

Stem Cells and Vaccines Production
- Dr Majid Mehtali, Vivalis

Doing our business a little bit differently than the others in the industry
- Dr Mads Krogsgaard, Novo Nordisk

Triggering Regenerative Functions with Transplanted Cells and Small Molecules
- Dr Kurt Stoeckli, Biological Sciences/Discovery Sanofi-Aventis

Stem Cell Research in GlaxoSmithKline and Beyond
- Dr Patrick Vallance, GlaxoSmithKline Drug Discovery

Stem Cells – Failings and Deliveries
- Hugh Ilyine, Consultant & Guest Editor

Patenting Stem Cells
- Dr. Sebastian Tegethoff, 24IP

Drug Testing with Embryonic Stem Cells – Towards Standards For Assays
– Dr David C Hay, University of Edinburgh, MRC Centre for Regenerative Medicine

L’Oréal avance dans les cellules souches
- Report by Hélène Guyot (with summary in English)

Buy the Entire Collection of Articles on Stem Cells here

If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

REALATED ARTICLES

No Mercy with Violators of Corporate Compliance

Dr Rüdiger Scheitza, Member of the Board Bayer CropScience, and Labour Director

Related Articles

Roche Ethiopia: Build-up of an emerging market

The Global Dimension of EU Health and Food Policies

Stem Cell Insights Collection 2010

Issues and Evaluation from Pharma Leaders

Top 10 Tags

All Tags (2094)

Lesezeichen / Weitersagen